journal article·2022-10-05

Fluorination of Polyethylenimines for Augmentation of Antibacterial Potency via Structural Damage and Potential Dissipation of Bacterial Membranes

Anzhi Wang, Shun Duan, Yang Hu, Xiaokang Ding, Fu-Jian Xu

ACS Applied Materials & Interfaces· Volume 14· Issue 39
Publisher page

Abstract

The rise of drug-resistant bacteria (e.g., methicillin-resistant Staphylococcus aureus, MRSA) has continued, making the ″super-bugs″ a formidable threat to global health. Herein, we synthesize a series of fluoroalkylated polyethylenimines (PEI-F) with different grafting degrees of fluoroalkyls via a simple ring-opening reaction and demonstrate for the first time that fluoroalkylated PEIs are able to exert potent antibacterial activity to Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus). Among the fluoroalkylated polymers, PEI-F3.0 shows the strongest antibacterial activity, with a minimum inhibitory concentration (MIC) of 64 μg mL–1, against both E. coli and S. aureus. More importantly, we find that PEI-F3.0 is able to kill over 99.8% of S. aureus within 1 min, which is extremely desirable for the treatment of acute and severe bacterial infections that require quick disinfection. We also demonstrate that the fluoroalkylated PEIs are able to kill bacteria via structural damage of the outer membrane (OM) and cytoplasmic membrane (CM), potential dissipation of CM, and generation of intracellular reactive oxygen species (ROS). The in vivo antibacterial test suggests that commercial Vaseline blended with 6.25 wt % of PEI-F3.0 (VL/PEI-F3.0) is able to efficaciously eradicate MRSA infection on a bacterial infected wound model and promote the healing procedure of the wound site. Therefore, the fluoroalkylated PEIs provide a promising strategy to cope with the major challenges of drug-resistant infections.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Antimicrobial agents and applications · Bacterial biofilms and quorum sensing · Antimicrobial Peptides and Activities

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Chemical Resource Engineering, Key Lab of Biomedical Materials of Natural Macromolecules (Beijing University of Chemical Technology, Ministry of Education), Beijing Laboratory of Biomedical Materials, Beijing 100029, P.R. China

College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, P.R. China

Funding

Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China · Beijing Outstanding Young Scientist Program · Joint Project of BRC-BC (Biomedical Translational Engineering Research Center of BUCT-CJFH)

References (50)

Show source-provided references
1. 10.1126/science.abl599710.1126/science.abl5997 ↗
2. 10.1038/nature.2017.2155010.1038/nature.2017.21550 ↗
3. 10.1002/adfm.20180214010.1002/adfm.201802140 ↗
4. 10.1002/smll.20190099910.1002/smll.201900999 ↗
5. 10.1016/j.pmatsci.2021.10088710.1016/j.pmatsci.2021.100887 ↗
6. 10.1016/j.jmst.2020.07.02810.1016/j.jmst.2020.07.028 ↗
7. 10.1002/adfm.20201116510.1002/adfm.202011165 ↗
8. 10.1021/acsami.7b1888910.1021/acsami.7b18889 ↗
9. 10.1021/acs.langmuir.9b0274710.1021/acs.langmuir.9b02747 ↗
10. 10.1021/acsami.7b0705310.1021/acsami.7b07053 ↗
11. 10.1038/nmat291510.1038/nmat2915 ↗
12. 10.1039/C8BM01483C10.1039/C8BM01483C ↗
13. 10.1021/acsnano.9b0928210.1021/acsnano.9b09282 ↗
14. 10.1039/D0BM00617C10.1039/D0BM00617C ↗
15. 10.1002/adhm.20190060810.1002/adhm.201900608 ↗
16. 10.1021/acs.biomac.8b0027010.1021/acs.biomac.8b00270 ↗
17. 10.1039/C9BM01726G10.1039/C9BM01726G ↗
18. 10.1039/C9BM00248K10.1039/C9BM00248K ↗
19. 10.1021/acsami.9b0291510.1021/acsami.9b02915 ↗
20. 10.1021/acsami.8b0111710.1021/acsami.8b01117 ↗
21. 10.1002/mabi.20120005210.1002/mabi.201200052 ↗
22. 10.1039/C6TB01929C10.1039/C6TB01929C ↗
23. 10.1039/C4TB01447B10.1039/C4TB01447B ↗
24. 10.1002/anie.20150869510.1002/anie.201508695 ↗
25. Sakakibara K. · Chem. Commun. · 2006 · 31 · 333410.1039/b606693c ↗
26. 10.1039/C9BM01738K10.1039/C9BM01738K ↗
27. 10.1002/adfm.20190193210.1002/adfm.201901932 ↗
28. 10.1039/C6PY01242F10.1039/C6PY01242F ↗
29. 10.1021/acsami.6b1140210.1021/acsami.6b11402 ↗
30. 10.1021/ja108325510.1021/ja1083255 ↗
31. 10.1021/acsbiomaterials.1c0125310.1021/acsbiomaterials.1c01253 ↗
32. 10.1021/acssuschemeng.1c0671410.1021/acssuschemeng.1c06714 ↗
33. 10.1016/j.biomaterials.2009.07.03010.1016/j.biomaterials.2009.07.030 ↗
34. 10.1186/s12906-020-2837-510.1186/s12906-020-2837-5 ↗
35. 10.1101/cshperspect.a00041410.1101/cshperspect.a000414 ↗
36. 10.1016/j.bbamem.2014.05.03110.1016/j.bbamem.2014.05.031 ↗
37. 10.1073/pnas.051018210310.1073/pnas.0510182103 ↗
38. 10.1099/00221287-143-10-319310.1099/00221287-143-10-3193 ↗
39. 10.1016/j.tim.2019.12.00810.1016/j.tim.2019.12.008 ↗
40. 10.1021/acsinfecdis.5b0011410.1021/acsinfecdis.5b00114 ↗
41. 10.1016/S0169-409X(01)00107-710.1016/S0169-409X(01)00107-7 ↗
42. 10.1038/s41467-018-03779-810.1038/s41467-018-03779-8 ↗
43. 10.1038/ncomms405310.1038/ncomms4053 ↗
44. 10.1073/pnas.181277911510.1073/pnas.1812779115 ↗
45. 10.1128/MMBR.67.4.593-656.200310.1128/MMBR.67.4.593-656.2003 ↗
46. 10.1038/s41579-021-00638-010.1038/s41579-021-00638-0 ↗
47. 10.1002/anie.20200050510.1002/anie.202000505 ↗
48. 10.1039/D0BM01211D10.1039/D0BM01211D ↗
49. 10.1007/s11051-010-0128-710.1007/s11051-010-0128-7 ↗
50. 10.1038/sj.bjp.070577610.1038/sj.bjp.0705776 ↗